While other studies have also identified additional mechanisms mediating KEAP1-NRF2 function in ferroptosis governance in other cellular or cancer contexts29,54–56, our study strongly suggests that, at least in lung cancer, FSP1 is a key effector to mediate ferroptosis resistance downstream of KEAP1-NRF2. The gene discussed is NFE2L2; the disease is cancer.